Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Inflammatory Bowel Diseases |
Free Subscription
2 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
Crohn's disease after surgery: Changes in post-operative management strategies
over time and their impact on long-term re-operation rate-A retrospective
multicentre real-world study.
Aliment Pharmacol Ther. 2024 Apr 14. doi: 10.1111/apt.18001.
PubMed
Abstract available
Application of clinical decision support tools for predicting outcomes with
vedolizumab therapy in patients with inflammatory bowel disease: A KASID
multicentre study.
Aliment Pharmacol Ther. 2024 Apr 14. doi: 10.1111/apt.17989.
PubMed
Abstract available
Level of interleukin 17 in inflammatory bowel disease and its relation with
disease activity.
BMC Gastroenterol. 2024;24:135.
PubMed
Abstract available
Inflammatory bowel disease patients' perspectives of non-medical needs.
BMC Gastroenterol. 2024;24:134.
PubMed
Abstract available
Real-World Outcomes of Patients Starting Intravenous and Transitioning to
Subcutaneous Vedolizumab in Inflammatory Bowel Disease.
Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08422.
PubMed
Abstract available
A Response-able Diagnosis: Type 2 Autoimmune Pancreatitis in the Setting of
Ulcerative Colitis.
Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08408.
PubMed
Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis.
Dig Dis Sci. 2024;69:1102-1104.
PubMed
Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an
Acute Care Setting.
Dig Dis Sci. 2024;69:1105-1109.
PubMed
Abstract available
Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided
Colitis and Pancolitis.
Dig Dis Sci. 2024;69:1389-1402.
PubMed
Abstract available
Risk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?
Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08262.
PubMed
Long-term outcomes of intestinal penetrating Crohn's disease following successful
nonoperative management.
Eur J Gastroenterol Hepatol. 2024 Apr 5. doi: 10.1097/MEG.0000000000002775.
PubMed
Abstract available
Biological treatment approach to inflammatory bowel disease is similar in
academic and nonacademic centres - prime time for decentralisation of
inflammatory bowel disease care?
Eur J Gastroenterol Hepatol. 2024 Apr 2. doi: 10.1097/MEG.0000000000002771.
PubMed
Abstract available
Antidepressant treatment in inflammatory bowel disease: a systematic review and
meta-analysis.
Eur J Gastroenterol Hepatol. 2024 Apr 5. doi: 10.1097/MEG.0000000000002768.
PubMed
Abstract available
AGA Clinical Practice Update on Pain Management in Inflammatory Bowel Disease:
Commentary.
Gastroenterology. 2024 Apr 17:S0016-5085(24)00358.
PubMed
Abstract available
Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two
years in patients with inflammatory bowel disease.
Gastroenterology. 2024 Apr 15:S0016-5085(24)00423.
PubMed
Exploring the Predictive Value of Gut Microbiome Signatures for Therapy
Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up
Study.
Inflamm Bowel Dis. 2024 Apr 18:izae064. doi: 10.1093.
PubMed
Abstract available
In Patients With Inflammatory Bowel Disease, Racial Disparities Exist in Burden
of Vaccine-preventable Disease Hospitalizations and Outcomes.
J Clin Gastroenterol. 2024 Apr 16. doi: 10.1097/MCG.0000000000002005.
PubMed
Abstract available
Avoidant/restrictive food intake disorder symptoms are not as frequent as other
eating disorder symptoms when ulcerative colitis is in remission.
J Crohns Colitis. 2024 Apr 18:jjae052. doi: 10.1093.
PubMed
Abstract available
Concordant B and T Cell Heterogeneity Inferred from the Multiomic Landscape of
Peripheral Blood Mononuclear Cells in a Crohn's Disease Cohort.
J Crohns Colitis. 2024 Apr 13:jjae055. doi: 10.1093.
PubMed
Abstract available
PANTS extension study: how best to use anti-TNF drugs in Crohn's disease.
Lancet Gastroenterol Hepatol. 2024 Apr 16:S2468-1253(24)00088.
PubMed
Mechanisms and management of loss of response to anti-TNF therapy for patients
with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort
study.
Lancet Gastroenterol Hepatol. 2024 Apr 16:S2468-1253(24)00044.
PubMed
Abstract available
Identifying Macrophage-Related Genes in Ulcerative Colitis Using Weighted
Coexpression Network Analysis and Machine Learning.
Mediators Inflamm. 2023;2023:4373840.
PubMed
Abstract available
Rauwolfia polysaccharide can inhibit the progress of ulcerative colitis through
NOS2-mediated JAK2/STAT3 pathway.
PLoS One. 2024;19:e0301660.
PubMed
Abstract available
Thank you for your interest in scientific medicine.